ATAI Life Sciences NVNASDAQ:ATAI
- LAST PRICE1.6351
- TODAY'S CHANGE (%)0.1151 (7.5724%)
- Bid / Lots1.6300/ 9
- Ask / Lots1.6400/ 9
- Open / Previous Close1.5200 / 1.5200
- Day Range
- 52 Week Range
- Volume1,667,107
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ATAI |
|---|---|---|
| 09:32 ET | 100856 | 1.451 |
| 09:33 ET | 24675 | 1.479 |
| 09:35 ET | 36886 | 1.5 |
| 09:37 ET | 18470 | 1.515 |
| 09:39 ET | 12689 | 1.5001 |
| 09:42 ET | 4985 | 1.52 |
| 09:44 ET | 16488 | 1.53 |
| 09:46 ET | 8210 | 1.52 |
| 09:48 ET | 51050 | 1.54 |
| 09:50 ET | 15146 | 1.53 |
| 09:51 ET | 8420 | 1.56 |
| 09:53 ET | 65690 | 1.555 |
| 09:55 ET | 14030 | 1.56 |
| 09:57 ET | 25772 | 1.55 |
| 10:00 ET | 28866 | 1.5495 |
| 10:02 ET | 1740 | 1.53 |
| 10:04 ET | 209 | 1.53 |
| 10:06 ET | 3667 | 1.525 |
| 10:08 ET | 9039 | 1.545 |
| 10:09 ET | 1020 | 1.545 |
| 10:11 ET | 6919 | 1.54 |
| 10:13 ET | 4860 | 1.55 |
| 10:15 ET | 26877 | 1.58 |
| 10:18 ET | 2700 | 1.59 |
| 10:20 ET | 9046 | 1.595 |
| 10:22 ET | 9115 | 1.5905 |
| 10:24 ET | 60858 | 1.62 |
| 10:26 ET | 13858 | 1.61 |
| 10:27 ET | 19169 | 1.6 |
| 10:29 ET | 11677 | 1.585 |
| 10:31 ET | 19983 | 1.5894 |
| 10:33 ET | 1817 | 1.586 |
| 10:36 ET | 5125 | 1.585 |
| 10:38 ET | 14884 | 1.615 |
| 10:40 ET | 7498 | 1.615 |
| 10:42 ET | 11892 | 1.61 |
| 10:44 ET | 15099 | 1.615 |
| 10:45 ET | 40091 | 1.6398 |
| 10:47 ET | 16696 | 1.65 |
| 10:49 ET | 18184 | 1.63 |
| 10:51 ET | 3000 | 1.63 |
| 10:54 ET | 3490 | 1.63 |
| 10:56 ET | 1190 | 1.64 |
| 10:58 ET | 300 | 1.63 |
| 11:00 ET | 1506 | 1.6398 |
| 11:02 ET | 11180 | 1.635 |
| 11:03 ET | 21896 | 1.62 |
| 11:05 ET | 17238 | 1.62 |
| 11:07 ET | 14910 | 1.6101 |
| 11:09 ET | 15283 | 1.61 |
| 11:12 ET | 4500 | 1.61 |
| 11:14 ET | 9526 | 1.62 |
| 11:16 ET | 25091 | 1.63 |
| 11:18 ET | 1500 | 1.64 |
| 11:20 ET | 4019 | 1.645 |
| 11:21 ET | 33509 | 1.62 |
| 11:23 ET | 7095 | 1.63 |
| 11:25 ET | 826 | 1.6289 |
| 11:27 ET | 13893 | 1.6249 |
| 11:30 ET | 66141 | 1.635 |
| 11:32 ET | 900 | 1.635 |
| 11:34 ET | 8089 | 1.635 |
| 11:36 ET | 11668 | 1.63 |
| 11:38 ET | 7546 | 1.6427 |
| 11:39 ET | 10088 | 1.65 |
| 11:41 ET | 8826 | 1.6512 |
| 11:43 ET | 23224 | 1.6606 |
| 11:45 ET | 3645 | 1.67 |
| 11:48 ET | 11050 | 1.66 |
| 11:50 ET | 9816 | 1.675 |
| 11:52 ET | 3037 | 1.675 |
| 11:54 ET | 7490 | 1.675 |
| 11:56 ET | 25494 | 1.68 |
| 11:57 ET | 2901 | 1.685 |
| 11:59 ET | 5680 | 1.69 |
| 12:01 ET | 15150 | 1.681 |
| 12:03 ET | 15451 | 1.69 |
| 12:06 ET | 14731 | 1.7094 |
| 12:08 ET | 11690 | 1.7024 |
| 12:10 ET | 11340 | 1.69 |
| 12:12 ET | 5072 | 1.7 |
| 12:14 ET | 8380 | 1.6801 |
| 12:15 ET | 1636 | 1.685 |
| 12:17 ET | 8480 | 1.69 |
| 12:19 ET | 18481 | 1.685 |
| 12:21 ET | 100 | 1.685 |
| 12:24 ET | 3763 | 1.685 |
| 12:26 ET | 3708 | 1.6953 |
| 12:28 ET | 12932 | 1.675 |
| 12:30 ET | 31804 | 1.66 |
| 12:32 ET | 4682 | 1.655 |
| 12:33 ET | 2784 | 1.65 |
| 12:35 ET | 6993 | 1.645 |
| 12:37 ET | 12738 | 1.645 |
| 12:39 ET | 1349 | 1.6406 |
| 12:42 ET | 1565 | 1.63 |
| 12:44 ET | 1100 | 1.6301 |
| 12:46 ET | 6547 | 1.645 |
| 12:48 ET | 28383 | 1.655 |
| 12:51 ET | 1100 | 1.66 |
| 12:53 ET | 4415 | 1.6506 |
| 12:55 ET | 200 | 1.655 |
| 12:57 ET | 2400 | 1.655 |
| 01:00 ET | 3200 | 1.658 |
| 01:02 ET | 1160 | 1.655 |
| 01:04 ET | 5016 | 1.65 |
| 01:06 ET | 3500 | 1.655 |
| 01:08 ET | 13316 | 1.67 |
| 01:09 ET | 1667 | 1.6607 |
| 01:11 ET | 5960 | 1.665 |
| 01:13 ET | 100 | 1.665 |
| 01:15 ET | 600 | 1.665 |
| 01:18 ET | 997 | 1.66 |
| 01:20 ET | 400 | 1.66 |
| 01:22 ET | 8945 | 1.65 |
| 01:24 ET | 63465 | 1.6377 |
| 01:26 ET | 400 | 1.63 |
| 01:27 ET | 1363 | 1.63 |
| 01:29 ET | 8777 | 1.635 |
| 01:31 ET | 180 | 1.635 |
| 01:33 ET | 460 | 1.63 |
| 01:36 ET | 900 | 1.635 |
| 01:38 ET | 400 | 1.63 |
| 01:40 ET | 9499 | 1.625 |
| 01:42 ET | 9337 | 1.64 |
| 01:44 ET | 3886 | 1.635 |
| 01:45 ET | 1360 | 1.635 |
| 01:47 ET | 2150 | 1.64 |
| 01:49 ET | 2523 | 1.64 |
| 01:54 ET | 800 | 1.63 |
| 01:56 ET | 100 | 1.635 |
| 01:58 ET | 500 | 1.6389 |
| 02:00 ET | 1300 | 1.6368 |
| 02:02 ET | 500 | 1.6351 |
Nov 18, 2024
DJ ATAI Life Sciences Is Maintained at Buy by HC Wainwright & Co., from 12:57PM ET on Monday Nov 18, 2024 by Dow Jones
12:57PM ET on Monday Nov 18, 2024 by Dow JonesDJ ATAI Life Sciences Is Maintained at Buy by Canaccord Genuity, from 9:27AM ET on Monday Nov 18, 2024 by Dow Jones
9:27AM ET on Monday Nov 18, 2024 by Dow Jones
Nov 13, 2024
atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates, from 8:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
8:00AM ET on Wednesday Nov 13, 2024 by Dow JonesPress Release: atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates, from 8:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
8:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 11, 2024
Altimmune Appoints Life Sciences Industry Veteran Greg Weaver as Chief Financial Officer, from 7:30AM ET on Monday Nov 11, 2024 by Dow Jones
7:30AM ET on Monday Nov 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ATAI Life Sciences NV | 255.1M | -2.0x | --- |
Lyell Immunopharma Inc | 255.9M | -1.2x | --- |
aTyr Pharma Inc | 250.1M | -3.3x | --- |
Eledon Pharmaceuticals Inc | 243.1M | -10.4x | --- |
Benitec Biopharma Inc | 236.8M | -1.9x | --- |
Atea Pharmaceuticals Inc | 274.5M | -1.6x | --- |
Company Information
ATAI Life Sciences NV is a Germany-based clinical-stage biopharmaceutical company. The Company engages in developing various treatments that focuses on various mental health disorders. The Company's therapeutic lead compound include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment; and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01, a formulation of N,N-dimethyltryptamine for treating TRD; EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder.
Contact Information
- Headquarters
- Wallstrasse 16Berlin, Germany 10179
- Phone
- 892-153-9035
- Fax
- ---
Executives
- Chairman of the Supervisory Board
- Christian Angermayer
- Co-Chief Executive Officer
- Florian Brand
- Co-Chief Executive Officer
- Srinivas Rao
- Chief Financial Officer
- Anne Johnson
- Chief Business Officer
- Sahil Kirpekar
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $255.1M |
|---|---|
Revenue (TTM) | $331.0K |
Shares Outstanding | 167.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.95 |
EPS | $-0.80 |
Book Value | $1.46 |
P/E Ratio | -2.0x |
Price/Sales (TTM) | 770.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -32,304.53% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
